SleepUp Digital CBTi-based Platform for Insomnia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorSleepUp Tecnologia em Saúde Ltda

About this trial

Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia and will be conducted in 2 phases.

Phase 1

The sample will be composed of 160 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild. Those who accept to participate will be randomized and distributed in four groups:

* Standard CBTi (CBTi-S): This treatment consists of an eight-week treatment composed by weekly and structure appointments with board-certified sleep psychologists. The appointments will be made remotely (video calls with psychologists). * Minimal intervention - Sleep hygiene (MI-SH): This group will receive an educational program on sleep hygiene through the SleepUp app. Its content covers topics that are also covered in the online CBTi sessions. This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral * Online CBTI (CBTI-O): This group will receive access to an eight-weeks CBTi-based treatment through the SleepUp app. The participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. * Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.

All participants in all groups will be assessed periodically throughout the eight weeks of intervention with standard sleep questionnaires and sleep logs. Equivalent intervals will be applied to the MI-SH group.

Phase 2

This phase will comprise 120 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild. Those who accept to participate will be randomized and distributed in three groups:

* Minimal intervention - Sleep hygiene (MI-SH): This group will receive an educational program on sleep hygiene through the SleepUp app. Its content covers topics that are also covered in the online CBTi sessions. This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral * Online CBTI (CBTI-O): This group will receive access to an eight-weeks CBTi-based treatment through the SleepUp app. The participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. * Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.

All participants in all groups will be assessed periodically throughout the eight weeks of intervention with standard sleep questionnaires and sleep logs. Equivalent intervals will be applied to the MI-SH group.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Literate Brazilian portuguese speakers.

Insomnia symptoms (as measured by ISI).

An Android-based smartphone or tablet with access to the Internet.

Disqualifiers

Previous experience with CBTi.

Use of sleeping pills or any other treatment for insomnia for two or more days a week in the last three months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Online Cognitive-Behavioral Therapy for Insomnia and complementary therapies

    Behavioral

    The CBTi-O and CBTi-O+ interventions are based on real life user experience. The users will have access to different versions of the platform. The intervention will last eitght weeks.

  • Regular Cognitive Behavioural Therapy for Insomnia

    Behavioral

    This is the gold standard behavioral treatment for insomnia and will be performed by independent board-certified sleep psychologists. The treatments will last eight weeks and the appointments will be made by video-calls.

  • Sleep hygiene - minimal intervention

    Behavioral

    It is composed by educational material about normal sleep pattern and sleep hygiene. It will be delivered by SleepUp app.

Treatment groups

280 Participants
are divided into 4 treatment groups
Group A: Standard CBTi (CBTi-S):Active comparator 1 intervention
Group B: Minimal intervention - Sleep hygiene (MI-SH):Placebo comparator 1 intervention
Group C: Online CBTI (CBTI-O)Experimental treatment 1 intervention
Group D: Online CBTi + additional features (CBTi-O+)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Adherence to the treatment

It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it. Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times. These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (MI-SH).

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks
2

Response to treatment

Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation.

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks
3

Remission of symptoms

Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8.

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks

Secondary outcomes

1

Self-reported sleep efficiency

Sleep efficiency will be measured by sleep logs

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks
2

Sleep hygiene

Sleep hygiene habits will be measured by the Sleep Hygiene Index

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks
3

Excessive daytime sleepiness

Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks
4

Sleep quality

Sleep quality will be measured by the Pittsburgh Sleep Quality Index

Time frame
From enrollment (baseline) to the end of treatment at 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.